Literature DB >> 16143309

Unique binding of a non-natural L,L,L-substrate by isopenicillin N synthase.

Annaleise R Howard-Jones1, Peter J Rutledge, Ian J Clifton, Robert M Adlington, Jack E Baldwin.   

Abstract

Isopenicillin N synthase (IPNS) is a non-haem iron oxidase that catalyses the formation of isopenicillin N from the tripeptide delta-(L-alpha-aminoadipoyl)-L-cysteinyl-D-valine. In this report, we describe the crystal structure of the enzyme with a non-natural L,L,L-tripeptide substrate, delta-(L-alpha-aminoadipoyl)-L-cysteinyl-L-3,3,3,3',3',3'-hexafluorovaline. This structure reveals a strong binding interaction of the tripeptide within the active site and a unique conformation for the non-natural L,L,L-diastereomer. Taken together, these findings provide a possible rationale for the previously observed inhibitory effects of L,L,L-tripeptide substrates on IPNS activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143309     DOI: 10.1016/j.bbrc.2005.08.155

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Biosynthetic process and strain improvement approaches for industrial penicillin production.

Authors:  Amol M Sawant; Koteswara Rao Vamkudoth
Journal:  Biotechnol Lett       Date:  2022-01-09       Impact factor: 2.461

2.  Reaction coordinate of isopenicillin N synthase: oxidase versus oxygenase activity.

Authors:  Christina D Brown-Marshall; Adrienne R Diebold; Edward I Solomon
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

3.  Terminally Truncated Isopenicillin N Synthase Generates a Dithioester Product: Evidence for a Thioaldehyde Intermediate during Catalysis and a New Mode of Reaction for Non-Heme Iron Oxidases.

Authors:  Luke A McNeill; Toby J N Brown; Malkit Sami; Ian J Clifton; Nicolai I Burzlaff; Timothy D W Claridge; Robert M Adlington; Jack E Baldwin; Peter J Rutledge; Christopher J Schofield
Journal:  Chemistry       Date:  2017-08-21       Impact factor: 5.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.